Rapid analytical methods for on-site triage for traumatic brain injury

Annual Review of Analytical Chemistry

Volumn 5, Issue , 2012, Pages 35-56

  North, Stella H ^a   Shriver Lake, Lisa C ^a   Taitt, Chris R ^a   Ligler, Frances S ^a  

^a NAVAL RESEARCH LABORATORY   (United States)

Author keywords

biomarkers; biosensors; pathophysiology; rapid detection; TBI

Indexed keywords

ACCELERATION AND DECELERATION; ANALYTICAL METHOD; BIOCHEMICAL MARKERS; BRAIN IMAGING; LOSS OF CONSCIOUSNESS; NEURONAL DAMAGE; PATHOPHYSIOLOGY; PHYSIOLOGICAL RESPONSE; QUANTITATIVE ASSESSMENTS; RAPID DETECTION; RAPID MEASUREMENT; TBI; TRAUMATIC BRAIN INJURIES;

BIOCHEMISTRY; BIOMARKERS; BRAIN; PHYSIOLOGICAL MODELS;

BIOSENSORS;

BIOLOGICAL MARKER;

ANIMAL; APOPTOSIS; BRAIN; BRAIN INJURY; ECONOMICS; GENETIC PROCEDURES; HUMAN; METABOLISM; METHODOLOGY; NERVE CELL; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; BIOSENSING TECHNIQUES; BRAIN; BRAIN INJURIES; HUMANS; NEURONS; OXIDATIVE STRESS;

EID: 84863308367     PISSN: 19361327     EISSN: 19361335     Source Type: Book Series    
DOI: 10.1146/annurev-anchem-062011-143105     Document Type: Review

References (110)

1. Cent. Dis. Control Prevent. 2011. Injury prevention and control: traumatic brain injury. http://www. cdc.gov/traumaticbraininjury
2. Int. Brain Inj. Assoc. 2010. Brain injury facts. http://www. internationalbrain.org/?q=braininjury- facts
3. Brain Inj. Assoc. Am. 2011. Living with brain injury. http://biausa.fyrian.com/living-with-brain-injury. htm
4. Brain Trauma Found. n.d. TBI statistics: facts about TBI in the USA. http://www.braintrauma.org/ tbi-faqs/tbi-statistics
5. Salisbury D, Novack T, Brunner R. 2005. TBI inform-traumatic brain injury caused by violence. http:// main.uab.edu/tbi/show.asp?durki=85704
6. Leland A, Oboroceanu M. 2010. American War and Military Operations Casualties: Lists and Statistics. Congr. Rep. Service Doc. FK32492
7. Terrio H, Brenner L, Ivins B, Cho JM, Helmick K, et al. 2009. Traumatic brain injury screening: preliminary findings in a U.S. Army brigade combat team. J. Head Trauma Rehabil. 24:14-23
8. Tanielian T, Jaycox LH, eds. 2008. Invisible Wounds of War: Psychological and Cognitive Injuries, Their Consequences, and Services to Assist Recovery. Santa Monica, CA: RAND Corp.
9. Galarneau M, Woodruff S, Dye J, Mohrle CR, Wade AL. 2008. Traumatic brain injury during Operation Iraqi Freedom: findings from the United States Navy-Marine Corps Combat Trauma Registry. J. Neurosurg. 108:950-57 (Pubitemid 351656843)
10. Ryan L. 2005. Traumatic brain injury (TBI ): challenges in 21st century warfare. Presented at Def. Veterans Brain Inj. Cent., Washington, DC
11. Def. Veterans Brain Inj. Cent. 2011. DoD worldwide numbers for traumatic brain injry. http://dvbic.org/ TBI-Numbers.aspx
12. US Dep. Def. 2011. DoD Report to Congress on Expenditures for Activities on Traumatic Brain Injury and Psychological Health, Including Posttraumatic Stress Disorder for 2010. Ref. ID: F-28E9BAD
13. Inst. Med. Natl. Acad. 2008. Gulf War and Health, vol. 7: Long-Term Consequences of Traumatic Brain Injury. Washington, DC: Natl. Acad. Press. http://www.nap.edu/openbook.php?record-id=12436&page=R1
14. Roberts G, Gentleman S, Lynch A, Murray L, Landon M, Graham DI. 1994. β-Amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 57:419-25
15. Ikonomovic MD, Uryu K, Abrahamson EE, Ciallella JR, Trojanowski JD, et al. 2004. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp. Neurol. 190:192-203 (Pubitemid 39335718)
16. Johnson V, Stewart W, Smith D. 2010. Traumatic brain injury and amyloid-â pathology: a link to Alzheimer's disease? Nat. Rev. Neurosci. 11:361-70
17. Holder S. 2008. The Glasgow Coma Scale. http://www.headbraininjuries.com/ glasgow-coma-scale
18. Def. Veterans Brain Inj. Cent. 2007. Military Acute Concussion Evaluation (MACE). http://www. pdhealth.mil/downloads/MACE.pdf
19. Def. Veterans Brain Inj. Cent. 2009. Military Acute Concussion Evaluation (MACE) information paper. http://www.dvbic.org/images/pdfs/providers/MACE- Information-Paper-V3.aspx
20. Vista Life Sci. 2011. Automated neuropsychological assessment metrics (ANAM4TM). http://www. vistalifesciences.com/anam4.html
21. ImPACT Appl. 2011. Overview and features of the ImPACT test. http://impacttest.com/about/ background
22. Def. Cent. Excell. 2011. Automated neuropsychological assessment metrics. http://www.dcoe.health.mil/ Content/Navigation/Documents/About%20ANAM.pdf
23. Brewin B. 2011. Battlefield brain-injury assessment tool has high failure rate. http://www.nextgov.com/ nextgov/ng-20110316-3265.php
24. Galetta KM, Barrett J, AllenM,Madda F, DelicataD, et al. 2011. The King-Devick test as a determinant of head trauma and concussion in boxers and MMA fighters. Neurology 76:1456-62
25. Le TH, Gean AD. 2009. Neuroimaging of traumatic brain injury. Mt. Sinai J. Med. 76:145-62
26. Holder S. 2008. MRI versus CT scan in determining brain injuries. http://www.headbraininjuries. com/brain-injuries-mri-ct-scan
27. Kou ZF, Wu Z, Tong KA, Holshauser B, Benson RR, et al. 2010. The role of advanced MR imaging findings as biomarkers of traumatic brain injury. J. Head Trauma Rehabil. 25:267-82
28. Lucas SM, Rothwell NJ, Gibson RM. 2006. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147:S232-40 (Pubitemid 43077281)
29. Lezlinger PM, Morganti-Kossmann M-C, Laurer HL, McIntosh TK. 2001. The duality of the inflammatory response to traumatic brain injury. Mol. Neurobiol. 24:169-81 (Pubitemid 34066684)
30. Raghupathi R. 2004. Cell death mechanisms following traumatic brain injury. Brain Pathol. 14:215-22 (Pubitemid 38656395)
31. Harting MT, Jimenez F, Adams SD, Mercer DW, Cox CS Jr. 2008. Acute, regional inflammatory response after traumatic brain injury: implications for cellular therapy. Surgery 144:803-13
32. Werner C, Engelhard K. 2007. Pathophysiology of traumatic brain injury. Br. J. Anaesth. 99:4-9 (Pubitemid 47072553)
33. Griesmaier E, Keller M. 2009. Neuroprotective strategies in excitotoxic brain injury: potential applications to the preterm brain. Future Neurol. 4:469-81
34. Yi J-H, Hazell AS. 2006. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Neurochem. Int. 48:394-403 (Pubitemid 43327279)
35. Sande A, West C. 2010. Traumatic brain injury: a review of pathophysiology and management. J. Vet. Emerg. Crit. Care 20:177-90
36. Zink BJ. 2001. Traumatic brain injury outcome: concepts for emergency care. Ann. Emerg.Med. 37:318-32 (Pubitemid 32204936)
37. Gouix E, Leveille F, Nicole O, Melon C, Had-Aissouni L, Buisson A. 2009. Reverse glial glutamate uptake triggers neuronal death through extrasynaptic NMDA receptor activation. Mol. Cell. Neurosci. 40:463-73
38. Blaylock R, Maroon J. 2011. Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-a unifying hypothesis. Surg. Neurol. Int. 2:107
39. Hemphill M, Dabiri B, Gabriele S, Kerscher L, Franck C, et al. 2011.Apossible role for integrin signaling in diffuse axonal injury. PLoS ONE 6:22899
40. Alford PW, Dabiri BE, Goss JA, Hemphill MA, Brigham MD, Parker KK. 2011. Blast-induced phenotypic switching in cerebral vasospasm. Proc. Natl. Acad. Sci. USA 108:12705-10
41. Zhang X, Chen Y, Jenkins LW, Kochanek PM, Clark RS. 2005. Bench-to-bedside review: apoptosis/programmed cell death triggered by traumatic brain injury. Crit. Care 9:66-75 (Pubitemid 40246773)
42. Yakovlev A, Faden A. 2001. Caspase-dependent apoptotic pathways in CNS injury. Mol. Neurobiol. 24:131-44 (Pubitemid 34066682)
43. Radi R, Denicola A, Alvarez B, Ferrer-Sueta G, Rubbo H. 2000. The biological chemistry of peroxynitrite. In Nitric Oxide: Biology and Pathobiology, ed. L Ignarro, pp. 57-82. San Diego: Academic
44. Dash P, Zhao J, Hergenroeder G, MooreA. 2010. Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury. Neurotherapeutics 7:100-14
45. Korfias S, Papadimitriou A, Stranjalis G, Bakoula C, Daskalakis G, et al. 2009. Serum biochemical markers of brain injury. Mini Rev. Med. Chem. 9:227-34
46. KoÜvesdi E, Lückl J, Bukovics P, Farkas O, Pál J, et al. 2010. Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics. Acta Neurochir. 152:1-17
47. Mehta SS. 2009. Biochemical serum markers in head injury: an emphasis on clinical utility. Clin. Neurosurg. 57:134-40
48. Bakay RA, Ward AA Jr. 1983. Enzymatic changes in serum and cerebrospinal fluid in neurological injury. J. Neurosurg. 58:27-37 (Pubitemid 13220944)
49. Berger RP, Hymel K, Gao W-M. 2006. The use of biomarkers after inflicted traumatic brain injury: insight into etiology, pathophysiology, and biochemistry. Clin. Pediatr. Emerg. Med. 7:186-93 (Pubitemid 44688635)
50. Reiber H. 2001. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin. Chim. Acta 310:173-86 (Pubitemid 32728347)
51. Petzold A. 2007. CSF biomarkers for improved prognostic accuracy in acute CNS disease. Neurol. Res. 29:691-708 (Pubitemid 350086068)
52. Romeo MJ, Espina V, Lowenthal M, Espina BH, Petricoin EF 3rd, Liotta LA. 2005. CSF proteome: a protein repository for potential biomarker identification. Expert Rev. Proteomics 2:57-70 (Pubitemid 40292580)
53. Bele S, Brawanski A. 2009. Biomarkers and surrogate markers. In Neurotrauma and Critical Care of the Brain, ed. J Jallo, CM Loftus, pp. 42-52. New York: Thieme Med. Publ.
54. Ingebrigtsen T, Romner B. 2002. Biochemical serum markers of traumatic brain injury. J. Trauma 52:798-808 (Pubitemid 34437255)
55. Streeter J, Hayes RL, Wang KKW. 2011. Diagnostic protein biomarkers for severe, moderate and mild traumatic brain injury. Proc. SPIE 8029:8029N1
56. Adkins JN, Varnum SM, Auberry KJ,Moore RJ, Angell NH, et al. 2002. Toward a human blood serum proteome. Mol. Cell. Proteomics 1:947-55
57. Anderson NL, Anderson NG. 2002. The human plasma proteome. Mol. Cell. Proteomics 1:845-67
58. Conrads TP, Hood BL, Veenstra TD. 2006. Sampling and analytical strategies for biomarker discovery using mass spectrometry. Biotechniques 40:799-805 (Pubitemid 46534921)
59. Ottens AK, Kobeissy FH, Golden EC, Zhang Z, Haskins WE, et al. 2006. Neuroproteomics in neurotrauma. Mass Spectrom. Rev. 25:380-408
60. Sun F, Cavalli V. 2010. Neuroproteomics approaches to decipher neuronal regeneration and degeneration. Mol. Cell. Proteomics 9:963-75
61. WangKKW,Ottens AK,LiuMC,Lewis SB,Meegan C, et al. 2005. Proteomic identification of biomarkers of traumatic brain injury. Expert Rev. Proteomics 2:603-14 (Pubitemid 41139842)
62. ZupancGKH.2007. Proteomics of traumatic brain injury and regeneration. Proteomics Clin.Appl. 1:1362-72
63. Cadosch D, Thyer M, Gautschi OP, Lochnit G, Frey SP, et al. 2010. Functional and proteomic analysis of serum and cerebrospinal fluid derived from patients with traumatic brain injury: a pilot study. Aust. N.Z. J. Surg. 80:542-47
64. Davidsson P,Westman-Brinkmalm A, NilssonCL, Lindbjer M, PaulsonL, et al. 2002. Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients. NeuroReport 13:611-15 (Pubitemid 34293477)
65. GaoW-M, ChadhaMS, Berger RP, Omenn GS, Allen DL, et al. 2007. A gel-based proteomic comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic brain injury. J. Neurotrauma 24:43-53 (Pubitemid 46214411)
66. HaskinsWE, Kobeissy FH,Wolper RA, Ottens AK, Kitten JW, et al. 2005. Rapid discovery of putative protein biomarkers of traumatic brain injury by SDS-PAGE-capillary liquid chromatography-tandem mass spectrometry. J. Neurotrauma 22:629-44 (Pubitemid 40840379)
67. Matt P, Fu Z, Fu Q, Van Eyk JE. 2008. Biomarker discovery: proteome fractionation and separation in biological samples. Physiol. Genomics 33:12-17 (Pubitemid 351451369)
68. Deutsch EW, Lam H, Aebersold R. 2008. PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows. EMBO Rep. 9:429-34 (Pubitemid 351627279)
69. Kingsmore SF. 2006. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 5:310-21
70. MacBeath G. 2002. Protein microarrays and proteomics. Nat. Genet. 32:526-32 (Pubitemid 35435157)
71. Whiteaker JR, Lin C, Kennedy J, Hou L, Trute M, et al. 2011. A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat. Biotechnol. 29:625-34
72. Kobeissy FH, Ottens AK, Zhang Z, Liu MC, Denslow ND, et al. 2006. Novel differential neuroproteomics analysis of traumatic brain injury in rats. Mol. Cell. Proteomics 5:1887-98 (Pubitemid 44688197)
73. Liu MC, Akinyi L, Scharf D, Mo J, Larner SF, et al. 2010. Ubiquitin C-terminal hydrolase L1 as a biomarker for ischemic and traumatic brain injury in rats. Eur. J. Neurosci. 31:722-32
74. Papa L, Akinyi L, Liu MC, Pineda JA, Tepas JJ 3rd, et al. 2010. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit. Care Med. 38:138-44
75. RifaiN,Gillette MA, Carr SA. 2006. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 24:971-83 (Pubitemid 44215392)
76. Pedersen B. 2000. Exercise and cytokines. Immunol. Cell Biol. 78:532-35
77. Hanash SM, Pitteri SJ, Faca VM. 2008. Mining the plasma proteome for cancer biomarkers. Nature 452:571-79 (Pubitemid 351483371)
78. Sanfilippo F, Li Volti G, Ristagno G, Murabito P, Pellis T, et al. 2010. Clinical biomarkers in brain injury: a lesson from cardiac arrest. Front. Biosci. 2:623-40
79. Anderson NL, AndersonNG, PearsonTW,Borchers CH, Paulovich AG, et al. 2009. A human proteome detection and quantitation project. Mol. Cell. Proteomics 8:883-86
80. Berger RP, Ta'asan S, Rand A, Lokshin A, Kochanek P. 2009. Multiplex assessment of serum biomarker concentrations in well-appearing children with inflicted traumatic brain injury. Pediatr. Res. 65:97-102
81. Siman R,ToraskarN,Dang A,McNeil E,McGarvey M, et al. 2009. A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J. Neurotrauma 26:1867-77
82. Manesh KM,Halámek J, Pita M, Zhou J, Tam TK, et al. 2009. Enzyme logic gates for the digital analysis of physiological level upon injury. Biosens. Bioelectron. 24:3569-74
83. Halámek J, Bocharova V, Chinnapareddy S, Windmiller JR, Strack G, et al. 2010. Multi-enzyme logic network architectures for assessing injuries: digital processing of biomarkers. Mol. Biosyst. 6:2554-60
84. Venkatasubbarao S, Dixon CE, Chipman R, Scherer A, Beshay M, et al. 2011. Field-based multiplex and quantitative assay platforms for diagnostics. Proc. SPIE 8029:80290P1
85. Sharma P, Benford B, Li ZZ, Ling GSF. 2009. Role of pyruvate dehydrogenase complex in traumatic brain injury and measurement of pyruvate dehydrogenase enzyme by dipstick test. J. Emerg. Trauma Shock 2:67-72
86. North SH, Shriver-Lake LC, Markwalter DW, Taitt CR, Jeromin A, Ligler FS. 2011. Biosensor triage for traumatic brain injury. Presented at Fed. Interag. Conf. Trauma. Brain Inj., Washington, DC
87. Mondello S, Muller U, Jeromin A, Streeter J, Hayes RL, Wang KK. 2011. Blood-based diagnostics of traumatic brain injuries. Expert Rev. Mol. Diagn. 11:65-78
88. Bobrow M, Harris T, Shaughnessy K, Litt G. 1989. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J. Immunol. Methods 125:279-85 (Pubitemid 20018033)
89. Kimberly HH, Shah S,Marill K, Noble V. 2008. Correlation of optic nerve sheath diameter with direct measurement of intracranial pressure. Acad. Emerg. Med. 15:201-4
90. Moretti R, Pizzi B, Cassini F, Vivaldi N. 2009. Reliability of optic nerve ultrasound for the evaluation of patients with spontaneous intracranial hemorrhage. Neurocrit. Care 11:406-10
91. McMullan JT, Knight WA, Clark JF, Beyette FR, Pancioli A. 2010. Time-critical neurological emergencies: the unfulfilled role for point-of-care testing. Int. J. Emerg. Med. 3:127-31
92. Emanuel P, Caples M. 2011. Chemical, Biological, Radiological Technology Survey. http://www. cbrnhorizonscan.com/resources/2012-horizon-scan-survey- 20110506.pdf
93. Bissonnette L, Bergeron MG. 2010. Diagnosing infections-current and anticipated technologies for point-of-care diagnostics and home-based testing. Clin. Microbiol. Infect. 16:1044-53
94. Clerc O, Greub G. 2010. Routine use of point-of-care tests: usefulness and application in clinical microbiology. Clin. Microbiol. Infect. 16:1054-61
95. Melo MR, Clark S, Barrio D. 2011. Miniaturization and globalization of clinical laboratory activities. Clin. Chem. Lab. Med. 49:581-86
96. Mohammed MI, Desmulliez MPY. 2011. Lab-on-A-Chip based immunosensor principles and technologies for the detection of cardiac biomarkers: a review. Lab Chip 11:569-95
97. Peeling RW, Mabey D. 2010. Point-of-care tests for diagnosing infections in the developing world. Clin. Microbiol. Infect. 16:1062-69
98. Yeo LY, ChangHC, Chan PPY, Friend JR. 2011. Microfluidic devices for bioapplications. Small 7:12-48
99. Jankovíc B, Horvat J, Djordjijevíc D, Ramah D, Fridman V, et al. 1991. Autoantibodies to S100, NSE, MBP in opiate-addicted humans. Infect. Dement. 58:113-26
100. Jankovíc B,DjordjijevícD. 1991. Differential appearance of autoantibodies to human brain S100 protein, neuron specific enolase and myelin basic protein in psychiatric patients. Int. J. Neurosci. 60:119-27
101. Poletaev A, Morozov S, Gnedenko B, Zlunikin VM, Korzhenevskey DA. 2000. Serum anti-S100β, anti-GFAP and anti-NGF autoantibodies of IgG class in healthy persons and patients with mental and neurological disorders. Autoimmunity 32:33-38 (Pubitemid 30636040)
102. Saatman K, Chuaime A-C, Bullock R, Maas AI, Valadka A, et al. 2008. Classification of traumatic brain injury for targeted therapies. J. Neurotrauma 25:719-39
103. Albert-Weissenberger C, Sirén A-L. 2010. Experimental traumatic brain injury. Exp. Transl. StrokeMed. 2:16
104. Cernak I. 2005. Animal models of head trauma. NeuroRx 2:410-22 (Pubitemid 41444875)
105. Frink M, Andruszkow H, Zeckey C, Krettek, C, Hildebrand F. 2011. Experimental trauma models: an update. J. Biomed. Biotechnol. 2011:797383
106. Anderson R, Hansson L-O,NilssonO,Dijlai-Merzoug R, SettergrenG. 2001. High serum S100βlevels for trauma patients without head injuries. Neurosurgery 48:1255-60 (Pubitemid 32472576)
107. Hoge C, McGurk D, Thomas JL, Cox AL, Engel CC, et al. 2008. Mild traumatic brain injury in U.S. soldiers returning from Iraq. N. Engl. J. Med. 358:453-63 (Pubitemid 351185801)
108. Cheng CM, Kim Y, Yang JM, Leuba SH, LeDuc PR. 2009. Dynamics of individual polymers using microfluidic based microcurvilinear flow. Lab Chip 9:2339-47
109. Olivecrona M, Rodling-Wahlström M, Naredi S, Koskinen L-OD. 2009. S-100β and neuron specific enolase are poor outcome predictors in severe traumatic brain injury treated by an intracranial pressure targeted therapy. J. Neurol. Neurosurg. Psychiatry 80:1241-48
110. Vos PE, Lamers KJB, Hendriks JC, van Haaren M, Beems T, et al. 2004. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 62:1303-10 (Pubitemid 38526041)